Reading Time: 3 minutes

CALGARY, Alberta, Oct. 09, 2019 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), an aspiring leader in analytical cannabis and hemp testing technologies, is pleased to be one of the featured presenters at the upcoming MjMicro conference in Beverley Hills, California. The conference, which will be held on October 16 at the Sofitel Hotel, is an invitational forum that unites publicly traded and emerging growth private cannabis companies led by seasoned executives with high net-worth investors and financial analysts.

FluroTech CEO, Danny Dalla Longa, will host a featured presentation to update investors and analysts on recent company milestones. “Rex Kary, FluroTech’s COO, will accompany me to MjMicro and we’re both looking forward to meeting individual and institutional investors with a focus on discussing investments and future growth plans including potential joint ventures,” stated Danny Dalla Longa. “Recent developments in our hemp testing capabilities along with an update on our biotracking technology should prove to be of great interest to attendees.”

The Company will be performing live onsite demos of the CompleTest™, demonstrating its accuracy, speed, ease-of-use, portability, and reliability at an affordable price.

About FluroTech (TSX-V: TEST) (OTCQB: FLURF)

FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.

To learn more, visit

Contact Information

Danny Dalla-Longa
Chief Executive Officer
[email protected]

FluroTech Ltd.
7 – 3535 Research Road NW
Calgary, AB T2L 2K8
[email protected]

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state and may not be offered or sold within the United States or to or for the benefit or account of U.S. persons, absent such registration or an applicable exemption from such registration requirements.

Cautionary Statement Regarding Forward-Looking Information

This news release contains “forward-looking information” within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer’s business, capital, technology or operations that is prospective in nature, and includes future-oriented financial information about the issuer’s prospective financial performance or financial position. The forward-looking information in this news release includes disclosure about the commercialization of the Company’s biotracker technology and timing thereof, the potential uses of the biotracker technology and the benefits thereof and the anticipated performance of the Company’s biotracker and CompleTest™ technologies.

The Company made certain material assumptions, including but not limited to prevailing market conditions and general business, economic, competitive, political and social uncertainties, the need and demand for the CompleTest™ and biotracker technology in the cannabis and hemp industry and the potential uses of the biotracker technology, to develop the forward-looking information in this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to, adverse market conditions and regulatory and other risks associated with the cannabis and hemp industries in general, users of the Company’s the CompleTest™ failing to achieve the anticipated benefits of the product, competition from other developers of similar technology, failure to reach commercialization of the technology and failure for the products anticipated market to develop. The Company cautions that the foregoing list of material risk factors and assumptions is not exhaustive.

The Company assumes no obligation to update or revise the forward-looking information in this news release, unless it is required to do so under Canadian securities legislation.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this release.